Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune check-point inhibitors

被引:0
|
作者
Looman, E. L. [1 ,2 ,3 ]
Cheng, P. F. [1 ,4 ]
Lai-Kwon, J. [5 ]
Morgan, L. [1 ]
Wakkee, M. [3 ]
Dummer, R. [1 ,4 ]
Dimitriou, F. [1 ,4 ]
机构
[1] Univ Hosp Zurich, Dermatol, Zurich, Switzerland
[2] Univ Hosp Zurich, Radiat Oncol, Zurich, Switzerland
[3] Erasmus MC, Dermatol, Rotterdam, Netherlands
[4] Univ Zurich, Fac Med, Zurich, Switzerland
[5] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
182
引用
收藏
页码:26S / 26S
页数:1
相关论文
共 50 条
  • [21] Health-related quality of life of rectal cancer survivors treated with curative intent
    Ferreira, A.
    Sardinha, M.
    Baleiras, M.
    Neves, M.
    Matos, A.
    Malheiro, M.
    Dutra, E.
    Rodrigues, C.
    Miguens, M.
    Guerreiro, I.
    da Luz, R.
    Martins, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S97 - S97
  • [22] Osteopenia and health-related quality of life in survivors of brain tumors treated in childhood
    Odame, I
    Duckworth, J
    Beaumont, L
    Talsma, D
    Furlong, W
    Webber, C
    Barrl, R
    NEURO-ONCOLOGY, 2004, 6 (04) : 441 - 441
  • [23] Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy
    Thompson, Jake R.
    Lai-Kwon, Julia
    Morton, Rachael L.
    Guminski, Alexander D.
    Gonzalez, Maria
    Atkinson, Victoria
    Sandhu, Shahneen
    Brown, Michael P.
    Menzies, Alexander M.
    McArthur, Grant A.
    Lo, Serigne N.
    Long, Georgina, V
    Bartula, Iris
    IMMUNOTHERAPY, 2023, : 593 - 610
  • [24] Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
    Aamdal, E.
    Skovlund, E.
    Jacobsen, K. D.
    Straume, O.
    Kersten, C.
    Herlofsen, O.
    Karlsen, J.
    Hussain, I
    Amundsen, A.
    Dalhaug, A.
    Nyakas, M.
    Hagene, K. T.
    Holmsen, K.
    Aamdal, S.
    Kaasa, S.
    Guren, T. K.
    Kyte, J. A.
    ESMO OPEN, 2022, 7 (05)
  • [25] Health-related quality of life measures and immune checkpoint inhibitors: A systematic review
    Ly, B.
    Walocko, F.
    Chen, S. C.
    Yeung, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S100 - S100
  • [26] Health-related quality of life measures and immune checkpoint inhibitors: A systematic review
    Walocko, Frances M.
    Ly, Bao Chau
    White, Mia S.
    Chen, Suephy C.
    Yeung, Howa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 1004 - 1006
  • [27] Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy
    Egeler, Mees
    Lai-Kwon, Julia
    Tissier, Renaud
    Fraterman, Itske
    Kuijpers, Anke
    Van Houdt, Winan
    Wilgenhof, Sofie
    Rao, Aparna
    Sandhu, Shahneen
    Lee, Rebecca
    Eriksson, Hanna
    van Leeuwen, Marieke
    de Ligt, Kelly
    van Akkooi, Alexander
    van de Poll-Franse, Lonneke
    EUROPEAN JOURNAL OF CANCER, 2024, 200
  • [28] Venous thromboembolism in patients with advanced non-small cell lung cancer treated with immune check-point inhibitors: a retrospective cohort study
    Icht, O.
    Darzi, N.
    Landman, Y.
    Reinhorn, D.
    Shochat, T.
    Jacobi, O.
    Rotem, O.
    Dudnik, E.
    Spectre, G.
    Raanani, P.
    Zer, A.
    Leader, A.
    THROMBOSIS RESEARCH, 2021, 200 : S49 - S50
  • [29] Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
    Rogiers, Anne
    Leys, Christophe
    Lauwyck, Justine
    Schembri, Adrian
    Awada, Gil
    Schwarze, Julia Katharina
    De Cremer, Jennifer
    Theuns, Peter
    Maruff, Paul
    De Ridder, Mark
    Bernheim, Jan L.
    Neyns, Bart
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [30] Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood
    Odame, I
    Duckworth, J
    Talsma, D
    Beaumont, L
    Furlong, W
    Webber, C
    Barr, RD
    BONE, 2005, 36 : S43 - S43